NCT00075621 - Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2000

Primary Completion Date

June 30, 2005

Study Completion Date

September 4, 2020

Conditions

Multiple Myeloma

Interventions

DRUG

filgrastim

16 mg/kg/day for 3 days prior to stem cell collection, through day before last collection

DRUG

melphalan

200 mg/kg over 2 days

PROCEDURE

autologous peripheral blood stem cell transplantation

Trial Locations (1)

Cancer Research Center at Boston Medical Center, Boston